The Cardiovascular Effects of Newer Antidepressants in Older Adults and Those With or At High Risk for Cardiovascular Diseases
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Cardiovascular Effects of Newer Antidepressants in Older Adults and Those With or At High Risk for Cardiovascular Diseases
Authors
Keywords
-
Journal
CNS DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-16
DOI
10.1007/s40263-020-00763-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- What is the evidence for mirtazapine in treating cancer-related symptomatology? A systematic review
- (2020) Guillaume Economos et al. SUPPORTIVE CARE IN CANCER
- Higher venlafaxine serum concentrations necessary for clinical improvement? Time to re-evaluate the therapeutic reference range of venlafaxine
- (2020) Maike Scherf-Clavel et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Effect of Venlafaxine on Electrocardiogram Intervals During Treatment for Depression in Older Adults
- (2020) Lauren M. Behlke et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Venlafaxine ER blocks the norepinephrine transporter in the brain of patients with major depressive disorder: a PET study using [18F]FMeNER-D2
- (2019) Ryosuke Arakawa et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Association between citalopram, escitalopram and QTc prolongation in a real-world geriatric setting
- (2019) Gabrielle Crépeau-Gendron et al. JOURNAL OF AFFECTIVE DISORDERS
- Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults
- (2019) Diana M. Sobieraj et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3
- (2019) Rachel Ochs-Ross et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Association of Antidepressant Use With Adverse Health Outcomes
- (2019) Elena Dragioti et al. JAMA Psychiatry
- Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions
- (2018) Patricio Riva-Posse et al. JOURNAL OF AFFECTIVE DISORDERS
- Effect of Escitalopram vs Placebo Treatment for Depression on Long-term Cardiac Outcomes in Patients With Acute Coronary Syndrome
- (2018) Jae-Min Kim et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Use of antidepressants and the risk of cardiovascular and cerebrovascular disease: a meta-analysis of observational studies
- (2017) A Biffi et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment
- (2017) Somaia Mohamed et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
- (2017) Gerard Sanacora et al. JAMA Psychiatry
- Antidepressants and antipsychotics classified with torsades de pointes arrhythmia risk and mortality in older adults - a Swedish nationwide study
- (2016) Bengt Danielsson et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The Role of Levomilnacipran in the Management of Major Depressive Disorder: A Comprehensive Review
- (2016) Antonio Bruno et al. Current Neuropharmacology
- Differential inhibition of cardiac and neuronal Na+ channels by the selective serotonin-norepinephrine reuptake inhibitors duloxetine and venlafaxine
- (2016) Carsten Stoetzer et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder
- (2016) Zeyad T. Sahli et al. Expert Opinion on Drug Discovery
- Vortioxetine: a New Treatment for Major Depressive Disorder
- (2016) K. Ryan Connolly et al. EXPERT OPINION ON PHARMACOTHERAPY
- Depression and coronary heart disease
- (2016) Robert M. Carney et al. Nature Reviews Cardiology
- Health Canada Warning on Citalopram and Escitalopram—Its Effects on Prescribing in Consultation-Liaison Psychiatry
- (2016) André Do et al. PSYCHOSOMATICS
- The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature
- (2016) André F. Carvalho et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care database
- (2016) Carol Coupland et al. BMJ-British Medical Journal
- Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care database
- (2016) Carol Coupland et al. BMJ-British Medical Journal
- Cause or Effect? Selective Serotonin Reuptake Inhibitors and Falls in Older Adults: A Systematic Review
- (2015) Marie Anne Gebara et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data
- (2015) Connie Sanchez et al. PHARMACOLOGY & THERAPEUTICS
- Cognitive Behavior Therapy for Depression and Self-Care in Heart Failure Patients
- (2015) Kenneth E. Freedland et al. JAMA Internal Medicine
- Antidepressant use and risk of coronary heart disease: meta-analysis of observational studies
- (2014) Seung-Won Oh et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary Syndrome: Systematic Review and Recommendations
- (2014) Judith H. Lichtman et al. CIRCULATION
- Levomilnacipran Extended-Release: A Review of Its Use in Adult Patients with Major Depressive Disorder
- (2014) Lesley J. Scott CNS DRUGS
- Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled trial
- (2014) Karla J. Alaka et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Adverse Cardiac Events in Older Patients Receiving Venlafaxine
- (2014) Joanne M. Ho et al. JOURNAL OF CLINICAL PSYCHIATRY
- Acute and Long-term Treatment of Late-Life Major Depressive Disorder: Duloxetine Versus Placebo
- (2013) Michael Robinson et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- The mechanism, efficacy, and tolerability profile of agomelatine
- (2013) Sarah E MacIsaac et al. EXPERT OPINION ON PHARMACOTHERAPY
- The Efficacy of Agomelatine in Elderly Patients With Recurrent Major Depressive Disorder
- (2013) Reinhard Heun et al. JOURNAL OF CLINICAL PSYCHIATRY
- Daily Oral Ketamine for the Treatment of Depression and Anxiety in Patients Receiving Hospice Care: A 28-Day Open-Label Proof-of-Concept Trial
- (2013) Scott A. Irwin et al. JOURNAL OF PALLIATIVE MEDICINE
- Bupropion for Smoking Cessation in Patients Hospitalized With Acute Myocardial Infarction
- (2013) Mark J. Eisenberg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Acute and subacute effects of the selective serotonin–noradrenaline reuptake inhibitor duloxetine on cardiac hERG channels
- (2013) F. Fischer et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- QTc Prolongation, Torsades de Pointes, and Psychotropic Medications
- (2013) Scott R. Beach et al. PSYCHOSOMATICS
- QT interval and antidepressant use: a cross sectional study of electronic health records
- (2013) V. M. Castro et al. BMJ-British Medical Journal
- A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder
- (2012) Cornelius Katona et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Mood and Pain Responses to Repeat Dose Intramuscular Ketamine in a Depressed Patient with Advanced Cancer
- (2012) Claudia Grott Zanicotti et al. JOURNAL OF PALLIATIVE MEDICINE
- Meta-Analysis of Selective Serotonin Reuptake Inhibitors in Patients With Depression and Coronary Heart Disease
- (2011) Carmine Pizzi et al. AMERICAN JOURNAL OF CARDIOLOGY
- Bupropion for Smoking Cessation in Patients With Acute Coronary Syndrome
- (2011) David Planer et al. ARCHIVES OF INTERNAL MEDICINE
- Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research
- (2011) Anna Meijer et al. GENERAL HOSPITAL PSYCHIATRY
- Effects of Milnacipran on Cardiac Repolarization in Healthy Participants
- (2010) Antonia Periclou et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Anxiety and Risk of Incident Coronary Heart Disease
- (2010) Annelieke M. Roest et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Depression in Patients with Coronary Heart Disease
- (2009) Robert M. Carney et al. AMERICAN JOURNAL OF MEDICINE
- Safety and Tolerability of Duloxetine at 60 mg Once Daily in Elderly Patients With Major Depressive Disorder
- (2009) Joel Raskin et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorder
- (2009) K. Hewett et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Megestrol Acetate and Mirtazapine for the Treatment of Unplanned Weight Loss in the Elderly
- (2009) Carol B Fox et al. PHARMACOTHERAPY
- Intravenous Ketamine “Burst” for Refractory Depression in a Patient with Advanced Cancer
- (2008) Lilianna Stefanczyk-Sapieha et al. JOURNAL OF PALLIATIVE MEDICINE
- Effectiveness and safety of venlafaxine extended release in elderly depressed patients
- (2007) Juan José Lopez Ibor et al. ARCHIVES OF GERONTOLOGY AND GERIATRICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started